PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50122C00080Venatorx pharmaceuticals: antibiotic for AMR and — Venatorx Pharmaceuticals, Inc

Venatorx Pharmaceuticals, Inc holds $44.4M across 6 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 1 related award in the incumbent pipeline. Competition previously drew 3 offers. Set-aside status: NONE. Recompete timing centers on the Dec 31, 2028 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma

Awarding office

Venatorx Pharmaceuticals, Inc

Recipient

Dec 31, 2028

PoP end

$72.1M

Obligated

541714

NAICS

6505

PSC

NONE

Set-aside

3 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Venatorx Pharmaceuticals, Inc — $90

Contract facts

NONE

Contract number75A50122C00080

AgencyBarda - Aspr / Daappo / Barda Dcma

Awarding officeBarda - Aspr / Daappo / Barda Dcma

IncumbentVenatorx Pharmaceuticals, Inc

UEIMBBKNBU5DCC6

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSC6505

Place of performanceMALVERN, PA

Related solicitation75A50122R00009

PoP end (current)Dec 31, 2028

PoP end (w/ options)Sep 22, 2032

Obligated$72.1M

VENATORX PHARMACEUTICALS: ANTIBIOTIC FOR AMR AND BIOTHREAT PATHOGENS is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by Venatorx Pharmaceuticals, Inc. Estimated value $72.1M ($72.1M obligated). Current period of performance ends Dec 31, 2028 (potential Sep 22, 2032). Last award drew 3 bidders. Place of performance: MALVERN, PA. Related solicitation 75A50122R00009.

VENATORX PHARMACEUTICALS: ANTIBIOTIC FOR AMR AND BIOTHREAT PATHOGENS

Recompete timing

Public

● Expiring in 846 days

Current PoP ends Dec 31, 2028 (846 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Jul 1, 2027.

Incumbent footprint

Public record

Venatorx Pharmaceuticals, Inc — $44.4M obligated across 6 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$44.8M · 100% of firm total

Open full company profile →

Related awards

Same incumbent

75N93020C00016

TO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-A…

$25.0M

Jan 18, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50122C00080?

75A50122C00080 (Venatorx pharmaceuticals: antibiotic for AMR and) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $72.1M, currently held by Venatorx Pharmaceuticals, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50122C00080?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50122C00080 to Venatorx Pharmaceuticals, Inc.

Who is the incumbent on 75A50122C00080?

Venatorx Pharmaceuticals, Inc is the incumbent with $44.4M across 6 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2028.

When does Venatorx Pharmaceuticals, Inc’s 75A50122C00080 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 31, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75A50122C00080 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 20, 2026 · refreshed monthlyLatest procurement action May 14, 2026